These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33896375)

  • 1. Direct oral anticoagulants and therapeutic adherence: do not let your guard down.
    Di Gennaro L; Monaco M; Riccio C; De Candia E; Alberelli MA; di Martino C; Basso M; Ferretti MA; Lancellotti S; De Cristofaro R
    Acta Cardiol; 2022 May; 77(3):243-249. PubMed ID: 33896375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation.
    Manzoor BS; Lee TA; Sharp LK; Walton SM; Galanter WL; Nutescu EA
    Pharmacotherapy; 2017 Oct; 37(10):1221-1230. PubMed ID: 28730619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription frequency and predictors for the use of novel direct oral anticoagulants for secondary stroke prevention in the first year after their marketing in Europe--a multicentric evaluation.
    Luger S; Hohmann C; Kraft P; Halmer R; Gunreben I; Neumann-Haefelin T; Kleinschnitz C; Walter S; Haripyan V; Steinmetz H; Foerch C; Pfeilschifter W
    Int J Stroke; 2014 Jul; 9(5):569-75. PubMed ID: 24828272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Ozaki AF; Choi AS; Le QT; Ko DT; Han JK; Park SS; Jackevicius CA
    Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005969. PubMed ID: 32148102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study.
    Anguita Sánchez M; Bertomeu Martínez V; Ruiz Ortiz M; Cequier Fillat Á; Roldán Rabadán I; Muñiz García J; Badimón Maestro L; Esteve Pastor MA; Marín Ortuño F;
    Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):14-20. PubMed ID: 31160265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
    Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
    Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation.
    Benzimra M; Bonnamour B; Duracinsky M; Lalanne C; Aubert JP; Chassany O; Aubin-Auger I; Mahé I
    Patient Prefer Adherence; 2018; 12():79-87. PubMed ID: 29379275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adequate Adherence to Direct Oral Anticoagulant is Associated with Reduced Ischemic Stroke Severity in Patients with Atrial Fibrillation.
    Yamashiro K; Kurita N; Tanaka R; Ueno Y; Miyamoto N; Hira K; Nakajima S; Urabe T; Hattori N
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1773-1780. PubMed ID: 30318259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol.
    Bhat Y; Dixit A; Mistri A; Patel B; Quoraishi SH; Uprichard J
    BMC Neurol; 2019 Nov; 19(1):306. PubMed ID: 31783738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to direct or vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a long-term observational study.
    Salmasi S; Safari A; De Vera MA; Högg T; Lynd LD; Koehoorn M; Barry AR; Andrade JG; Deyell MW; Rush KL; Zhao Y; Loewen P
    J Thromb Thrombolysis; 2024 Mar; 57(3):437-444. PubMed ID: 38103148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral anticoagulants adherence in elderly patients treated for atrial fibrillation in the era of direct oral anticoagulants].
    Drouin L; Gegu M; Mahe J; de Decker L; Berrut G; Chevalet P
    Ann Cardiol Angeiol (Paris); 2017 Sep; 66(4):197-203. PubMed ID: 28506577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism.
    Keita I; Aubin-Auger I; Lalanne C; Aubert JP; Chassany O; Duracinsky M; Mahé I
    Patient Prefer Adherence; 2017; 11():1625-1634. PubMed ID: 29026288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of direct oral anticoagulants in patients undergoing elective electrical cardioversion: A real-world patient population.
    de Heide J; de Wit A; Bhagwandien RE; Assaf A; Gros-Bisdom J; van der Meer KC; Wijchers SA; Zijlstra F; Szili-Torok T; Lenzen MJ; Yap SC
    Int J Cardiol; 2021 Mar; 326():98-102. PubMed ID: 33144120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study.
    Zielinski GD; van Rein N; Teichert M; Klok FA; Rosendaal FR; van der Meer FJM; Huisman MV; Cannegieter SC; Lijfering WM
    Pharmacoepidemiol Drug Saf; 2021 Aug; 30(8):1027-1036. PubMed ID: 33822401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of adherence, treatment satisfaction and knowledge of direct oral anticoagulants in atrial fibrillation patients.
    Moudallel S; van Laere S; Cornu P; Dupont A; Steurbaut S
    Br J Clin Pharmacol; 2022 May; 88(5):2419-2429. PubMed ID: 34907577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality of life of elderly people on oral anticoagulant for atrial fibrillation: VKA versus direct oral anticoagulants].
    Fareau S; Baumstarck K; Farcet A; Molines C; Auquier P; Retornaz F
    Geriatr Psychol Neuropsychiatr Vieil; 2015 Mar; 13(1):45-54. PubMed ID: 25786423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral anticoagulation in atrial fibrillation: What is the guideline for using new drugs?].
    Ibáñez Pérez de Viñaspre JA; Gómez Bitrian J; Royo Hernández R; de Azúa Jiménez M; Marco López C; Urieta González L
    Semergen; 2018; 44(5):297-303. PubMed ID: 28867369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of conflicting information from healthcare providers and poor shared decision making with suboptimal adherence in direct oral anticoagulant treatment: A cross-sectional study in patients with atrial fibrillation.
    Moudallel S; van den Bemt BJF; Zwikker H; de Veer A; Rydant S; Dijk LV; Steurbaut S
    Patient Educ Couns; 2021 Jan; 104(1):155-162. PubMed ID: 32622691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration.
    Borne RT; O'Donnell C; Turakhia MP; Varosy PD; Jackevicius CA; Marzec LN; Masoudi FA; Hess PL; Maddox TM; Ho PM
    BMC Cardiovasc Disord; 2017 Sep; 17(1):236. PubMed ID: 28865440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges of treatment adherence with direct oral anticoagulants in pandemic.
    Dittrich T; Polymeris A; De Marchis GM
    Curr Opin Neurol; 2021 Feb; 34(1):38-44. PubMed ID: 33230038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.